A need for refund flexibility
Multiple FDA-cleared devices exist, including laser caps, helmets, and combs
GLP-1 RAs showed trends toward improvements in endocrine and metabolic, cardiovascular, renal, and respiratory outcomes, cognitive function, with a potential reduction in fracture risk and all-cause mortality in certain populations
Conclusion The clinical utility of AOMs now extends far beyond weight reduction
Document PBS criteria : inadequate control on metformin SU/insulin, plus any SGLT2-i contraindication or prior failure if combining
Conversely, sacubitril/valsartan has been shown to increase PRA, ANG I and ANG II levels in a canine model of RAAS activation